Showing results (131-140 of 446) with videos related to

Sort By:
Pageof 45
Nature Reviews. Neurology|June 3, 2009
Imaging outcomes for neuroprotection and repair in multiple sclerosis trialsFrederik Barkhof, Peter A Calabresi, David H Miller, et al.
Cellular Immunology|August 13, 2013
Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cellsInna V Grishkan, Achilles Ntranos, Peter A Calabresi, et al.
Neuroimage. Clinical|March 15, 2017
Quantitative measures of walking and strength provide insight into brain corticospinal tract pathology in multiple sclerosisNora E Fritz, Jennifer Keller, Peter A Calabresi, et al.
Neuron|June 18, 2024
Neurodegeneration and demyelination in multiple sclerosisThomas Garton, Sachin P Gadani, Alexander J Gill, et al.
JCI Insight|October 6, 2017
Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementationPavan Bhargava, Kathryn C Fitzgerald, Peter A Calabresi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 17, 2019
Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measuresOlwen C Murphy, Ohemaa Kwakyi, Mustafa Iftikhar, et al.
Neurology|July 17, 2023
Effects of Ibudilast on Retinal Atrophy in Progressive Multiple Sclerosis Subtypes: Post Hoc Analyses of the SPRINT-MS TrialHenrik Ehrhardt, Jeffrey Lambe, Hussein Moussa, et al.
Neurology|November 2, 2012
PML-IRIS in a patient treated with brentuximabGloria von Geldern, Carlos A Pardo, Peter A Calabresi, et al.
European Journal of Immunology|May 17, 2023
Emerging imaging and liquid biomarkers in multiple sclerosisAlexander J Gill, Emily M Schorr, Sachin P Gadani, et al.
The Journal of Biological Chemistry|July 13, 2013
KLF4 modulates expression of IL-6 in dendritic cells via both promoter activation and epigenetic modificationJason M Rosenzweig, Justin D Glenn, Peter A Calabresi, et al.
Pageof 45